Valuation
Orthopedic, Prosthetic & Surgical Appliances & SuppliesLive · Yahoo FinancePrice
$83.82
52-Week Range
Decision Context
Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.
Based on filing period ending Mar 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.64%
Accommodative
10-Year Treasury
4.32%
2026-04-01
Unemployment
4.3%
Near full employment
CPI Index
330.3
2026-03-01
M2 Money Supply
$22.7T
2026-03-01
The Federal Funds rate stands at 3.64% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.32%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.3%; Industrial production index is at 101.8; M2 money supply is $22.7T; CPI index stands at 330.3.
SWOT Analysis — EW
Inflationary BoomStrengths
Operating Cash Flow: $1.6B (+194.2% YoY) — Operating cash flow grew 194% — the business generated more cash from day-to-day operations.
Revenue: $6.1B (+11.5% YoY) — Revenue grew 12% — the company sold more goods or services than the prior year.
Gross Profit: $4.7B (+9.5% YoY) — Gross profit rose 10% — the spread between revenue and direct costs improved.
Weaknesses
Net Income: $1.1B (-74.3% YoY) — Profit fell 74% but remained positive.
EPS (Diluted): $1.83 (-73.7% YoY) — Earnings per share fell 74%.
Opportunities
No clear opportunities identified at this time.
Threats
Net income dropped 74% year-over-year — a significant compression in profitability.
Financial Charts
Year-over-Year Changes
Operating Cash Flow
$1.6B
was $542.3M
Operating cash flow grew 194% — the business generated more cash from day-to-day operations.
Net Income
$1.1B
was $4.2B
Profit fell 74% but remained positive.
EPS (Diluted)
$1.83
was $6.97
Earnings per share fell 74%.
Revenue
$6.1B
was $5.4B
Revenue grew 12% — the company sold more goods or services than the prior year.
Gross Profit
$4.7B
was $4.3B
Gross profit rose 10% — the spread between revenue and direct costs improved.
Risk Flags
0 high · 1 medium · 0 low- ◈ Medium
Net income dropped 74% year-over-year — a significant compression in profitability.
Price History
Technical Signals
Daily closes · 1-year dataLatest News
via FinnhubGet the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade EW
Links open broker research pages. Not an endorsement or recommendation.
Research EDWARDS LIFESCIENCES CORPORATION
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.